Inhalation of rifapentine dry powder to shorten tuberculosis treatment
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Presentation
- By: TRAINI, Daniela (Woolcock Institute of Medical Research, Discipline of Pharmacology, Sydney Medical School, Sydney, Australia)
- Co-author(s): Chan, John Gar Yan (Woolcock Institute of Medical Research, Sydney, Australia)
Chan, Hak-Kim (Faculty of Pharmacy, The University of Sydney, Sydney, Australia)
Young, Paul (Woolcock Institute of Medical Research, Sydney, Australia)
Background: Treatment of tuberculosis (TB) using the standard oral antibiotic regimen is effective but inefficient, requiring high doses and lengthy treatment times. The introduction of shorter treatment regimens for TB could dramatically reduce disease incidence, associated mortality and enhance compliance (1). Standard treatment for active.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.